prof. dr. Pieter Van Vlierberghe
work address
De Pintelaan 185, ingang 38 (MRB2)
9000 Gent
9000 Gent
ORCID iD
0000-0001-9063-72051 – 10 of 111
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia
- T-ALL and thymocytes: a message of noncoding RNAs
- Long non-coding RNAs in leukemia: biology and clinical impact
- Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia
- The TLX1 oncogene modulates the enhancer RNA landscape in T-ALL
- 2016
- Expanding the TLX1 regulome in T-cell acute lymphoblastic leukemia towards long noncoding RNAs
- Genetic characterization and therapeutic targeting of MYC translocated pediatric T-cell acute lymphoblastic leukemia
- Fast generation of conditional ROSA26-based mouse models that recapitulate genomic events in human T-ALL
- Identification of candidate oncogenes and chromosomal breakpoint sequencing by targeted locus amplification in T-cell acute lymphoblastic leukemia
- PRC2 mutations induce resistance to conventional chemotherapy by inhibiting mitochondrial apoptosis in T-cell acute lymphoblastic leukemia